Rezende Thaís K L, Barbosa Helliomar P, Dos Santos Luiz F, de O Lima Karmel, Alves de Matos Patrícia, Tsubone Tayana M, Gonçalves Rogéria R, Ferrari Jefferson L
Laboratório de Desenvolvimento de Materiais Inorgânicos com Terras Raras-DeMITeR, Instituto de Química-(IQ), Universidade Federal de Uberlândia-(UFU), Uberlândia, Brazil.
Laboratório de Materiais Luminescentes Micro e Nanoestruturados-Mater Lumen, Departamento de Química, FFCLRP, Universidade de São Paulo-(USP), Uberlândia, Brazil.
Front Chem. 2022 Nov 17;10:1035449. doi: 10.3389/fchem.2022.1035449. eCollection 2022.
Light-based therapies and diagnoses including photodynamic therapy (PDT) have been used in many fields of medicine, including the treatment of non-oncological diseases and many types of cancer. PDT require a light source and a light-sensitive compound, called photosensitizer (PS), to detect and destroy cancer cells. After absorption of the photon, PS molecule gets excited from its singlet ground state to a higher electronically excited state which, among several photophysical processes, can emit light (fluorescence) and/or generate reactive oxygen species (ROS). Moreover, the biological responses are activated only in specific areas of the tissue that have been submitted to exposure to light. The success of the PDT depends on many parameters, such as deep light penetration on tissue, higher PS uptake by undesired cells as well as its photophysical and photochemical characteristics. One of the challenges of PDT is the depth of penetration of light into biological tissues. Because photon absorption and scattering occur simultaneously, these processes depend directly on the light wavelength. Using PS that absorbs photons on "optical transparency windows" of biological tissues promises deeper penetration and less attenuation during the irradiation process. The traditional PS normally is excited by a higher energy photon (UV-Vis light) which has become the Achilles' heel in photodiagnosis and phototreatment of deep-seated tumors below the skin. Thus, the need to have an effective upconverter sensitizer agent is the property in which it absorbs light in the near-infrared (NIR) region and emits in the visible and NIR spectral regions. The red emission can contribute to the therapy and the green and NIR emission to obtain the image, for example. The absorption of NIR light by the material is very interesting because it allows greater penetration depth for bioimaging and can efficiently suppress autofluorescence and light scattering. Consequently, the penetration of NIR radiation is greater, activating the biophotoluminescent material within the cell. Thus, materials containing Rare Earth (RE) elements have a great advantage for these applications due to their attractive optical and physicochemical properties, such as several possibilities of excitation wavelengths - from UV to NIR, strong photoluminescence emissions, relatively long luminescence decay lifetimes (µs to ms), and high sensitivity and easy preparation. In resume, the relentless search for new systems continues. The contribution and understanding of the mechanisms of the various physicochemical properties presented by this system is critical to finding a suitable system for cancer treatment PDT.
包括光动力疗法(PDT)在内的基于光的治疗和诊断方法已在医学的许多领域得到应用,包括非肿瘤疾病和多种癌症的治疗。PDT需要一个光源和一种称为光敏剂(PS)的光敏化合物来检测和破坏癌细胞。在吸收光子后,PS分子从其单重基态激发到更高的电子激发态,在几个光物理过程中,它可以发光(荧光)和/或产生活性氧(ROS)。此外,生物反应仅在已接受光照的组织特定区域被激活。PDT的成功取决于许多参数,如光在组织中的深度穿透、非靶细胞对PS的更高摄取以及其光物理和光化学特性。PDT的挑战之一是光进入生物组织的穿透深度。由于光子吸收和散射同时发生,这些过程直接取决于光的波长。使用在生物组织的“光学透明窗口”吸收光子的PS有望在照射过程中实现更深的穿透和更少的衰减。传统的PS通常由高能光子(紫外-可见光)激发,这已成为皮肤下深部肿瘤光诊断和光治疗的致命弱点。因此,需要有一种有效的上转换敏化剂,其特性是在近红外(NIR)区域吸收光并在可见光和近红外光谱区域发射光。例如,红色发射可有助于治疗,绿色和近红外发射可用于成像。材料对近红外光的吸收非常有趣,因为它允许在生物成像中实现更大的穿透深度,并能有效抑制自发荧光和光散射。因此,近红外辐射的穿透更深,可激活细胞内的生物光致发光材料。因此,含有稀土(RE)元素的材料由于其吸引人的光学和物理化学性质,如从紫外到近红外的多种激发波长可能性、强光致发光发射、相对较长的发光衰减寿命(微秒到毫秒)以及高灵敏度和易于制备,在这些应用中具有很大优势。总之,对新系统的不懈探索仍在继续。了解该系统呈现的各种物理化学性质的机制并做出贡献对于找到适合癌症治疗PDT的系统至关重要。
Front Chem. 2022-11-17
Acta Biomater. 2017-3-15
ACS Appl Mater Interfaces. 2019-5-30
ACS Appl Mater Interfaces. 2018-12-17
Chem Soc Rev. 2016-10-5
Dalton Trans. 2018-2-16
Int J Mol Sci. 2023-2-14
Exploration (Beijing). 2022-3-17
Ophthalmic Epidemiol. 2023-6
Colloids Surf B Biointerfaces. 2022-5